Interim Results Of A Phase I/Ii Study Of Ocrelizumab, A New Humanised Anti-Cd20 Antibody In Patients With Relapsed/Refractory Follicular Non-Hodgkin'S LymphomaFranck Morschhauser,Paula Marlton,Umberto Vitolo,Ola Linden,John F Seymour, M Crump,Bertrand Coiffier,Alessandro Pulsoni,Andrew R Belch,E Lerch,Eva Kimby,K Arnljots, E Wassner,Myriam MendilaBLOOD(2007)引用 19|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要